Dr. Rizwan Romee works at Harvard Medical School/Dana Farber Cancer Institute since March 2018. Before this Dr. Romee received his MD from Govt. Medical College Srinagar, India in 2003. He completed his postgraduate training and hematology and oncology fellowship at University of Minnesota in 2011. He did his post-doctoral training in Dr. Jeffrey S. Miller’s laboratory at University of Minnesota followed by advanced BMT fellowship and post-doctoral training in Dr. Todd Fehniger’s laboratory at Washington University School of Medicine in 2012. At Dana Farber Cancer Institute (DFCI) and Harvard Medical School, Dr Romee’s goal is to expand the use of NK-cell based studies in patients with advanced hematologic malignancies and also to test them in combination with other novel agents to potentially further enhance their anti-tumor activity.